즐거운 강의되기 바랍니다 June 28, 2002.

Slides:



Advertisements
Similar presentations
Neoplasia II: Tumor Characteristics
Advertisements

Leicester Warwick Medical School Neoplasia 1 What is a Tumour? Professor Rosemary A Walker Department of Pathology.
Neoplasia Nomenclature
ONCOLOGY Dr. Walid Daoud Assistant Professor. Oncology Oncology is the study of tumors (neoplasms) - Benign neoplasm:. Growth of the same cells as the.
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Neoplasia.
Dr. Bruce F. Burns Anatomical Pathology Ottawa Hospital
Neoplasia I Introduction Husni Maqboul, M.D. Terminology Tumor : Pathologic disturbance of growth, characterized by excessive and unnecessary proliferation.
Introduction to Neoplasia
Section 7 Nomenclature and classification. All tumors (benign and malignant) have two basic components. Proliferating neoplastic cells that constitute.
Abdulmalik Alsheikh, M.D, FRCPC Dr. Maha Arafah, MBBS, KSFP
Neoplasia Lecture 1 Definition and Nomenculature Dr. Maha Arafah
Epidemiology 242: Pathology Basis of Caner Jian-Yu Rao, MD Professor of Pathology and Epidemiology Fall, 2009.
Neoplasia Dr. Raid Jastania. Neoplasia: Terminology Cancer is the 2 nd cause of death in the US Neoplasia is “new growth” Neoplasm is an abnormal mass.
Weeks 6 and 7 Neoplasia Dr.İ.Taci Cangül Bursa-2008.
NEOPLASIA Definitions of terms used in neoplasia
Neoplasia Lecture 2 Dr. Maha Arafah.
Chapter 4 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Pathology of Neoplasia. Neoplasia Shashi-Aug-15 Introduction:  Inflammatory, Degenerative & Neoplastic  Growth – Increase in size due to synthesis of.
Tumor 2 Pathology and Histology.
NEOPLASIA DR.ROOPAPathophysiology Premed 2. Neoplasia Neoplasm is an abnormal mass of tissue as a result of neoplasia. Neoplasm is an abnormal mass of.
DR.ROOPA Pathophysiology Premed 3
Neoplasia I Walter C. Bell, M.D..
Abdulmalik Alsheikh, MD, FRCPC
Neoplasia. 3- Rate of growth  Most benign tumours grow slowly over a period of years, whereas most cancers grow rapidly, spread locally and to distant.
NEOPLASIA Nadia Ismiil, MD, FRCPC.
Introduction to Cancer
Dr. Salma Mansoor Lecturer, DCOP, DUHS
Principles of Surgical Oncology Salah R. Elfaqih.
Systemic Pathology. Neoplasia -Abnormal cell growth.
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Abdulmalik Alsheikh, MD, FRCPC
Neoplasia-2.
Neoplasia Lecture 1 Dr. Maha Arafah. Neoplasia Upon completion of these lectures, the student should: Define a neoplasm. Contrast neoplastic growth with.
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Path 822: Experimental Cancer Diagnostics & Therapeutics: PATHOLOGY OF TUMOURS Sandip SenGupta, M.D. Professor of Pathology September 2005.
Neoplasia Lecture 1 Maha Arafa,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC.
TUMORS and NEOPLASM.
CANCER HCT !. OBJECTIVES  Define and understand the difference between benign and malignant tumors  Students will be able to identify the classifications.
Classification of Tumors
Neoplasia 1. a) Definition b) Terminologies Neoplasia “new growth” Definition: “an abnormal growth of tissue, the growth of which exceed and is uncoordinated.
NEOPLASIA Def.: persistent abnormal
Neoplasia Lecture 2 Maha Arafah,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS EPIDEMIOLOGY CHARACTERISTICS OF.
Principles of Surgical Oncology
Neoplasia Lecture 1 Maha Arafa,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC.
Dr. Osama I Nassif. MD, FRCPC. Associate professor & consultant pathologist. Pathology Dept. King Abdulaziz University. NEOPLASIA بسم الله الرحمن الرحيم.
N EOPLASIA 1 D R. HIBA AL ZOU ’ BI. - Neoplasia literally means "new growth“ - In medicine it is referred to as a tumor, - The study of tumors is called.
Malignant Epithelial Tumors
Neoplasia Lecture 1 Abdulmalik Alsheikh, M.D, FRCPC Dr. Maha Arafah, MBBS, KSFP Foundation block 2013 Pathology Foundation block 2013 Pathology Definition.
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Neoplasia I: Tumor Nomenclature
NEOPLASIA Dr. Manal Maher Hussein.
In describing a person’s cancer what would T2 mean? In describing a person’s cancer what does M1 mean? In describing a person’s cancer what does N0 mean?
Thanaa Helal Professor of Pathology Faculty of Medicine – Ain Shams University.
Neoplasia Basics, Grading and Staging Kimiko Suzue MD, Ph.D. Department of Pathology Mt. Sinai Hospital.
Neoplasia By Prof.Dr. Ahmed Mohy El Din Intended Learning Outcomes (ILOs): Define neoplasia: Differentiate neoplastic from non neoplastic lesions. Classify.
Unit 7 Neoplasia Neoplasm is an abnormal mass of tissue as a result of neoplasia Neoplasia (new growth in Greek) is the abnormal proliferation of cells.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Classification of Tumours Professor of Pathology
Nomenclature & Characteristics of Tumours Neoplasia 1
NEOPLASIA H.A. MWAKYOMA, MD.
CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
Chapter 5 Tumor , neoplasm Department of pathology.
Principles of Surgical Oncology
CLASSIFICATION OF TUMORS
Classification of Tumors
Abdulmalik Alsheikh, MD, FRCPC
Vocabulary of Neoplasia
Neoplasia means literally “new growth”
Presentation transcript:

즐거운 강의되기 바랍니다 June 28, 2002

General Characteristics of Neoplasms Jae Y. Ro, M.D. Asan Medical Center Seoul, Korea June 28, 2002

single organism, cell, or gene Clone : A group of genetically identical descended (progeny) produced by asexual reproduction of single organism, cell, or gene Cancer : Clonal overgrowth Cell proliferation Cell loss

Cancer Incidence Age, sex, race, socioeconomic groups men: 684/100,000 Luxembourg 84/100,000 El Salvador women: 450/100,000 Denmark 126/100,000 El Salvador USA, men 361/100,000 women 283/100,000 Korea, Japan, China: lower than USA

Ten Leading Cancer Sites for the Estimated New Cancer Cases and Deaths by Gender, US, 2002 *

Cancer Statistics in Korea (1/1999 - 12/1999) 1) Stomach (20.7%) 6) Uterine cervix (5.0%) 2) Lung (12.1%) 7) Thyroid (3.5%) 3) Liver (12.0%) 8) Hematopoietic (2.9%) 4) Colon ( 9.9%) 9) Bladder (2.4%) 5) Breast ( 6.4%) 10) Pancreas (2.2%)

For Men 1) Stomach (24.2%) 6) Esophagus (3.2%) 2) Liver (16.3%) 7) Hematopoietic (2.9%) 3) Lung (16.1%) 8) Prostate (2.5%) 4) Colon ( 9.7%) 9) Pancreas (2.4%) 5) Bladder ( 3.3%) 10) Kidney (1.8%)

For Women 1) Stomach (16.2%) 6) Lung (6.7%) 2) Breast (14.7%) 7) Liver (6.3%) 3) Uterine Cervix (11.6%) 8) Ovary (4.2%) 4) Colon (10.2%) 9) Hematopoietic (2.9%) 5) Thyroid ( 6.8%) 10) Pancreas (2.0%)

Definition Neoplasm = new growth Tumor : swelling caused by inflammation : equated with neoplasm Oncology (Greek oncos = tumor) Cancer : common term for all malignant tumors (Latin for crab = cancer) Neoplasm = abnormal mass of tissue 1) exceed growth and uncoordinated with that of normal tissue 2) persists after cessation of stimuli 3) autonomous, purposeless, preys on host

Nomenclature (I) Two basic components : Proliferating neoplastic cells (parenchyma) and supportive stroma (medullary/scirrhous) Benign tumors - oma to cell of origin (mesenchymal tumors) - oma to cell of origin, microscopic architecture, macroscopic patterns (epithelial tumors) Malignant tumors - sarcoma (Greek, sar = fleshy) (mesenchymal tumors) - carcinoma (epithelial tumors) Mixed tumor - divergent differentiation of a single line of parenchymal cells - epithelial & myoepithelial cell (pleomorphic adenoma) Teratoma - more than one germ layer

Nomenclature of Tumors Tissue of Origin Benign Malignant Composed of One Parenchymal Cell Type Mesenchymal tumors Connective tissue and derivatives Fibroma Fibrosarcoma Lipoma Liposarcoma Chondroma Chondrosarcoma Endothelial and related tissue Blood vessels Hemangioma Angiosarcoma Lymph vessels Lymphangioma Lymphangiosarcoma Synovium Synovial sarcoma Mesothelium Mesothelioma Brain coverings Meningioma Invasive meningioma Blood cells and related cells Hematopoietic cells Leukemia Lymphoid tissue Malignant lymphoma Muscle Smooth Leiomyoma Leiomyosarcoma Striated Rhabdomyoma Rhabdomyosarcoma Epithelial tumors Stratified squamous Squamous cell papilloma Squamous cell or epidermoid carcinoma Basal cells of skin or adnexa Basal cell carcinoma Epithelial lining Glands or ducts Adenoma Adenocarcinoma Papilloma Papillary carcinoma Cystadenoma Cystadenocarcinoma

Nomenclature of Tumors Tissue of Origin Benign Malignant Composed of One Parenchymal Cell Type Respiratory passages Bronchogenic ca Bronchial adenoma (carcinoid) Neuroectoderm Nevus Malignant melanoma Renal epithelium Renal tubular adenoma Renal cell carcinoma Liver cells Liver cell adenoma Hepatocellular ca Urinary tract epithelium (transitional) Transitional cell papilloma Transitional cell ca Placental epithelium (trophoblast) Hydatidiform mole Choriocarcinoma Testicular epithelium (germ cells) Seminoma Embryonal carcinoma More Than One Neoplastic Cell Type-Mixed Tumors, Usually Derived From One Germ Layer Salivary glands Pleomorphic adenoma Malig mixed tumor of (mixed tumor of salivary origin) salivary gland Breast Fibroadenoma Malignant cystosarcoma phyllodes Renal anlage Wilms tumor More Than One Neoplastic Cell Type Derived From More Than One Germ Layer-Teratogenous Totipotential cells in gonads Mature teratoma, dermoid cyst Immature teratoma, or in embryonic rests teratocarcinoma

Nomenclature (II) Choristoma - ectopic rest of normal tissue Hamartoma - produce a mass of disorganized but mature specialized cells or tissue indigenous to particular site Differentiation - parenchymal cells resemble comparable normal cells, both morphologically and functionally Anaplasia - lack of differentiation, dedifferentiation - hallmark of malignant transformation - morphologic and functional change * Metaplasia * Dysplasia - loss of polarity, size & shape irregularity * Tumor of borderline malignancy, low grade malignancy, uncertain malignant potential

Characteristics of Benign & Malignant neoplasms 1. Differentiation and Anaplasia 2. Rate of growth 3. Growth patterns 4. Metastasis a) seeding of body cavities and surfaces b) lymphatic spread c) hematogenous spread

Benign vs Malignant Well diff: structure typical of tissue of origin slow growth, mitoses rare and normal expansile and encapsulated no metastasis Lack of diff with anaplasia: structure atypical rapid growth, mitoses numerous and abnormal infiltrative and no capsule metastases

An Approach to the Morphologic Diagnosis of Cancer

Morphologic DX of Cancer Lesions Infectious Mesenchymal Non-neoplastic Epithelial Neoplastic Non-Infectious Benign Malignant (carcinoma) (sarcoma)

Neoplastic vs Non-neoplastic

Neoplastic vs Non-neoplastic

Epithelial vs Mesenchymal oval, round or polygonal cell nests desmoplastic stroma vessels in stroma spindle diffuse no desmoplastic stroma vessels between tumor cells

Epithelial vs Mesenchymal

Epithelial vs Mesenchymal oval, round or polygonal cell nests desmoplastic stroma vessels in stroma spindle diffuse no desmoplastic stroma vessels between tumor cells

Epithelial vs Mesenchymal

Epithelial vs Mesenchymal oval, round or polygonal cell nests desmoplastic stroma vessels in stroma spindle diffuse no desmoplastic stroma vessels between tumor cells

Epithelial vs Mesenchymal

Epithelial vs Mesenchymal oval, round or polygonal cell nests desmoplastic stroma vessels in stroma spindle diffuse no desmoplastic stroma vessels between tumor cells

Epithelial vs Mesenchymal

Epithelial vs Mesenchymal oval, round or polygonal cell nests desmoplastic stroma vessels in stroma spindle diffuse no desmoplastic stroma vessels between tumor cells

Epithelial vs Mesenchymal

e.g., sarcomatoid ca, sarcoma with epithelioid cells, lymphoma, melanoma, NE tumors, small round cell tumors

Immunostain, EM and molecular analysis

Benign vs Malignant Well diff: structure typical of tissue of origin slow growth, mitoses rare and normal expansile and encapsulated no metastasis Lack of diff with anaplasia: structure atypical rapid growth, mitoses numerous and abnormal infiltrative and no capsule metastasis

Malignant Tumors high cellularity necrosis nuclear features enlarged nuclear size (N/C ratio) pleomorphism prominent nucleoli hyperchromatism increased mitoses (atypical mitoses)

Malignant Tumor

Malignant Tumor

Malignant Tumor

Classification of Tumors cellular origin microscopic architectures macroscopic (gross) architectures differentiation (H & E stain) electron microscopic findings immunohistochemistry molecular pathology

Prognostic Factors Category I (well supported): stage, grade Category II (extensively studied but not well established): DNA ploidy, nuclear proliferation, angiogenesis, apoptosis, tumor suppressor gene Category III (currently studying): other oncogenes, cytogenetic analysis, growth factors, detection of circulating tumor cells in blood

TNM Classification T (tumor), N (node) & M (metastasis) Primary tumor (T) TX Primary tumor cannot be assessed T0 No evidence of primary tumor Tis Carcinoma in situ T1-T4 Increasing size and/or local extent (depth of invasion) of tumor

TNM Classification Regional lymph nodes (N) NX Regional lymph nodes cannot be assessed N0 No regional lymph node metastasis N1-N3 Increasing involvement of regional lymph node * Direct extension of tumor into a lymph node classified as a lymph node metastasis ** Metastasis in other than regional lymph nodes classified as a distant metastasis *** Tumor nodule up to 3mm in greatest extent is classified in T category. If tumor nodule is greater than 3mm without evidence of residual lymph node tissue, classified as a lymph node metastasis Distant metastasis (M) MX Distant metastasis cannot be assessed M0 No distant metastasis M1 Distant metastasis

Stage Grouping (Lung Ca) Stage 0 Tis N0 M0 Stage IA T1 N0 M0 Stage IB T2 N0 M0 Stage IIA T1 N1 M0 Stage IIB T2 (T3) N1 (N0) M0 Stage IIIA T1-T3 N1, N2 M0 Stage IIIB Any T N3 M0 T4 Any N M0 Stage IV Any T Any N M1

Tumor Grade malignant tumors (Arabic no. 1,2,-- ) histologic grade (overall proportional) original Broders’ grading (4 tier) modified Broders' grading (3 tier) high and low grade (2 tier) nuclear grade (worst areas) Black NG for breast ca. Fuhrman’s NG for renal cell ca.

Information for Pathologists demographic data (age, sex, DOB---) name of specimens type of procedures date specimen obtained Submitting physicians symptoms, signs and duration abnormal lab findings image findings preop- and postop clinical diagnosis

Information for Clinicians diagnosis (benign, malignant, uncertain malignant potential): in malignant tumor--grade tumor size/depth of invasion margins; structure involvement vascular invasion nodal status treatment response other abnormalities

Summaries Definition, nomenclatures Neoplastic vs non-neoplastic, epithelial vs mesenchymal, benign vs malignant Type of tumors: architectural patterns, differentiation of cells H&E staining, EM, immunohistochemistry and molecular pathology Prognostic factors: stage and grade

여러분 감사 합니다